MedTrace Logo

Phase I Trial Evaluating the Pharmacokinetics of Single Ascending Oral Doses of IRL757 in Healthy Elderly Volunteers

NCT06699628 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-02-05

Study results available
· View outcomes & findings →

Summary

This is a phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers.

Conditions

  • Not Applicable as This is a Mass Balance/Pharmacokinetic Study Performed in Healthy Subjects
  • Apathy

Interventions

DRUG

IRL757

IRL757 capsules

Sponsors & Collaborators

  • Integrative Research Laboratories AB

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-23
Primary Completion
2024-11-11
Completion
2024-11-11

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06699628 on ClinicalTrials.gov